What Is SCHD’s New High Really Made Of

What Is SCHD's New High Really Made Of?

The fund is near its peak, but cashing out a quality compounder is often the costliest choice of all.

The Schwab US Dividend Equity ETF (SCHD) holds 103 positions, but its ten largest holdings make up 41% of the fund, giving you a concentrated dose of established American companies. This fund, which aims to track the Dow Jones U.S. Dividend Index, just closed at $32.80, putting it within 0.7% of its 52-week high. After a solid run, it's natural to wonder if this is a peak you should sell.

How Strong Was The Run-Up?

A new high built on a narrow set of winners can be fragile. Here, the story is more nuanced. The fund returned +5.8% over the past three months, an advance that was mixed but not dangerously concentrated. While 21 of the 30 largest holdings rose, participation wasn't universal. Still, the three biggest movers accounted for only about 25% of the fund move, meaning no small handful of stocks did all the work. The basket itself is also reasonably diversified, spanning 8 sectors across its largest holdings, with Health Care being the biggest at about 24% of that group. This isn't a speculative fever dream; it's a measured advance across multiple industries.

Is The Fund Stretched Or Just Doing Its Job?

The fund now sits about 10.2% above its 200-day moving average, so it has clearly outpaced its own recent trend. And on valuation, the basket trades at about 19.5 times earnings, noticeably richer than its roughly 5-year median of 16.8. That premium deserves attention. But it's also important to remember the fund's character. Its annualized price volatility over the past year is about 11%, and its deepest fall from a high in recent years was 16.8%. This is a relatively steady vehicle, not a high-flyer prone to sudden collapses. The current price, while elevated, reflects the performance of the quality companies it holds.

So, What Is The Right Move Here?

When a well-diversified fund hits a high on a broad-ish advance, it's often just compounding at work. A new high, by itself, is not a signal to sell. The classic mistake is to interrupt a quality compounder for fear of a garden-variety pullback, only to miss out on years of future growth. For a long-term holder, the most sensible action is very often to do nothing at all. The only strong reason to act might be to trim the position back toward its target weight in your portfolio if the run-up has made it oversized. Resisting the impulse to sell a winner is a common challenge for investors. The real danger isn't that the fund gives back some gains, but that you exit a core holding and never find the right moment to get back in.

Is There A Stronger ETF To Own Instead?

Whether you are inclined to keep holding or tempted to take the gain and look elsewhere, the same question follows: is there simply a better ETF to own right now? A new high tells you the price is up, not whether SCHD still stacks up against its peers on valuation, return, and risk.

Our ETF Valuation and Performance Scorecard ranks the major ETFs side by side on exactly those measures, so you can see at a glance whether SCHD is still near the top of the pack or whether your money could work harder somewhere else.

A Fund Is Only Part Of Your Portfolio, Check The Rest

A fund is just one piece of what you own, and the same scrutiny applies to every other position in your portfolio. How much damage any single position could do to your net worth is a question with a precise answer. The Trefis Wealth team computes it for investors professionally, with the same rules-based systematic discipline that runs our High Quality Portfolio. Request a free vulnerability audit of your biggest positions.